- Home
- NRXP vs CCM Comparison
NRXP vs CCM Comparison
Compare NRXP & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- CCM
- Stock Information
- Founded
- NRXP 2015
- CCM 1997
- Country
- NRXP United States
- CCM China
- Employees
- NRXP N/A
- CCM N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- NRXP Health Care
- CCM Health Care
- Exchange
- NRXP Nasdaq
- CCM Nasdaq
- Market Cap
- NRXP 58.5M
- CCM 33.3M
- IPO Year
- NRXP N/A
- CCM 2009
- Fundamental
- Price
- NRXP $2.83
- CCM $5.36
- Analyst Decision
- NRXP Strong Buy
- CCM
- Analyst Count
- NRXP 4
- CCM 0
- Target Price
- NRXP $28.50
- CCM N/A
- AVG Volume (30 Days)
- NRXP 137.7K
- CCM 16.2K
- Earning Date
- NRXP 08-13-2025
- CCM 09-26-2025
- Dividend Yield
- NRXP N/A
- CCM N/A
- EPS Growth
- NRXP N/A
- CCM N/A
- EPS
- NRXP N/A
- CCM N/A
- Revenue
- NRXP N/A
- CCM $52,603,198.00
- Revenue This Year
- NRXP N/A
- CCM N/A
- Revenue Next Year
- NRXP $230.95
- CCM N/A
- P/E Ratio
- NRXP N/A
- CCM N/A
- Revenue Growth
- NRXP N/A
- CCM N/A
- 52 Week Low
- NRXP $1.10
- CCM $3.80
- 52 Week High
- NRXP $6.01
- CCM $10.77
- Technical
- Relative Strength Index (RSI)
- NRXP 38.54
- CCM 41.17
- Support Level
- NRXP $2.89
- CCM $5.04
- Resistance Level
- NRXP $3.15
- CCM $5.77
- Average True Range (ATR)
- NRXP 0.14
- CCM 0.89
- MACD
- NRXP -0.04
- CCM 0.01
- Stochastic Oscillator
- NRXP 10.22
- CCM 3.14
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.